Literature DB >> 9249622

A study of visual hallucinations in patients with Parkinson's disease.

C Klein1, D Kömpf, U Pulkowski, A Moser, P Vieregge.   

Abstract

In a hospital-based case-control study 29 patients with idiopathic Parkinson's disease (PD) and visual hallucinations (VH) were compared with 58 PD patients matched for age and disease duration, but without VH. VH patients had more frequently sleep disturbances and dementia, higher PD-related disability (Schwab-England scale), and took selegiline more frequently as an anti-Parkinsonian drug. The patient groups did not differ in age at PD onset, Webster score, treatment duration, dosage of any anti-Parkinsonian drug, frequency of levodopa-associated movement disorders, or measures on brain CT. After a median follow-up period of 27 months more VH patients had developed wearing-off and freezing phenomena, while their scores in the Mini Mental State Examination were lower. Nursing home placement during the follow-up period was associated with higher PD-related disability in VH patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249622     DOI: 10.1007/s004150050104

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Relationship between age and subtypes of psychotic symptoms in Parkinson's disease.

Authors:  Günes Kiziltan; Sibel Ozekmekçi; Sibel Ertan; Turan Ertan; Ethem Erginöz
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

Review 2.  [Parkinson's disease and psychoses].

Authors:  Jacopo Vittoriano Bizzarri; Giancarlo Giupponi; Ignazio Maniscalco; Patrizia Schroffenegger; Andreas Conca; Hans Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2015-01-14

Review 3.  Visual hallucinations in Parkinson's disease: a review and phenomenological survey.

Authors:  J Barnes; A S David
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

Review 4.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 5.  Dementia with Lewy bodies.

Authors:  Tanis J Ferman; Bradley F Boeve
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

6.  Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease.

Authors:  James M Shine; Joanna M Z Mills; Jessica Qiu; Claire O'Callaghan; Zoe Terpening; Glenda M Halliday; Sharon L Naismith; Simon J G Lewis
Journal:  Mov Disord Clin Pract       Date:  2015-03-16

7.  Neurotoxic N-methyl-D-aspartate lesion of the ventral midbrain and mesopontine junction alters sleep-wake organization.

Authors:  Y Y Lai; T Shalita; T Hajnik; J P Wu; J S Kuo; L G Chia; J M Siegel
Journal:  Neuroscience       Date:  1999-05       Impact factor: 3.590

8.  Clinical Outcomes in Patients with Parkinson's Disease Treated with a Monoamine Oxidase Type-B inhibitor: A Cross-Sectional, Cohort Study.

Authors:  Khashayar Dashtipour; Jack J Chen; Camellia Kani; Khaled Bahjri; Mark Ghamsary
Journal:  Pharmacotherapy       Date:  2015-07-03       Impact factor: 4.705

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.